Advocacy Actions
European Chamber Co-organises EU-China Biopharmaceutical Innovation and Development Roundtable
On 24th November 2022, the EU-China Biopharmaceutical Innovation and Development Roundtable took place using a hybrid format connecting Beijing and Brussels.
The roundtable, co-organised by the European Chamber and the China Society for Drug Regulation (CSDR), with the support from the European Federation of Pharmaceutical Industries and Associations (EFPIA), enabled an open dialogue on pro-innovation regulatory policies between representatives from the European pharmaceutical industry and the National Medical Products Administration (NMPA).
European Chamber Attended CCPIT 2022 Third-quarter Roundtable with Foreign Businesses
On 9th September, European Chamber attended the quarterly online roundtable with foreign chambers and enterprises for the third quarter of 2022, hosted by the Department of Development Research of the China Council for the Promotion of International Trade (CCPIT).
European Chamber Attended CCPIT 2022 First Quarter Online Seminar with FIEs
On 25th March, the European Chamber attended the 2022 First Quarter Online Seminar on Business Environment for Foreign-invested Enterprises in China, organized by the research department of the China Council for the Promotion of International Trade (CCPIT).
Submission of Comments on Draft Measures on Security Assessment of the Cross-border Transfer of Data
At the end of October, the Cybersecurity Administration of China (CAC) published a invitation to public consultation on the Measures on Security Assessment of the Cross-border Transfer of Data (Draft for comments).
Read moreChief Negotiator for CAI debriefs European Chamber representatives on the Agreement
On 5th January, Chief Negotiator for the Comprehensive Agreement on Investment (CAI) Ms Maria Martin Prat and her team debriefed a group of Chamber industry representatives on the key points of the Agreement.
Read moreSubmitted comments to the NPC on the Biosecurity Law
The National People’s Congress (NPC) issued a call for comments on the Biosecurity Law (the second draft for review) with an official deadline on 13th June.
Read moreComments to SAMR on Draft Revisions to the Anti-monopoly Law of the People's Republic of China (Draft for Comment)
The European Chamber very much welcomes the SAMR's decision to collect opinions on the "Draft Revisions to the Anti-monopoly Law of the People's Republic of China (Draft for Comment)". Upon careful study of the draft and consultation with its members, the European Union Chamber of Commerce in China, led by its Legal and Compliance Working Group, has collated all member inputs and submitted suggestions to the SAMR Anti-monopoly Bureau for their consideration.
Read moreComments to Ministry of Science and Technology (MOST) on Safety Management Regulations for Biotechnology Research and Development (Call for Comments)
Following the Ministry of Science and Technology (MOST)' s ’s call for comments on the Safety Management Regulations for Biotechnology Research and Development (Call for Comments), and upon circulation of the draft within relevant working groups, the European Chamber has collated all member inputs and submitted to MOST.
Read moreMeeting with Legislative Affairs Commission of the NPC Standing Committee and SCOFCOM on the Draft Foreign Investment Law
On February 22, 2019, the Legislative Affairs Committee of the Standing Committee of the National People's Congress and the Shanghai Municipal Commission of Commerce hosted a symposium to solicit opinions on the draft Foreign Investment Law. Representative of the European Chamber's Legal & Competition Working Group attended the symposium and presented members’ feedback and concerns.
Read moreLetter to Medical Insurance Department of MOHRSS on Drug Renaming in NRDL
Letter to Medical Insurance Department of MOHRSS on Drug Renaming in NRDL
Read more